Synthesis of novel AZA-analogues of tiazofurin with 2-[5,5- bis(Hydroxymethyl)Pyrrolidin-2-yl] framework as sugar mimic

Nucleosides, Nucleotides and Nucleic Acids

Volumn 31, Issue 1, 2012, Pages 72-84

  Mironiuk Puchalska, Ewa ^a   Koszytkowska Stawiska, Mariola ^a   Sas, Wojciech ^a   De Clercq, Erik ^b   Naesens, Lieve ^b  

^a WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Pyrrolidine synthesis; thiazole synthesis; tiazofurin aza analogues

Indexed keywords

2 [5,5 BIS(HYDROXYMETHYL)PYRROLIDIN 2 YL]; CYSTEINE ETHYL ESTER; SUGAR; SUGAR NUCLEOTIDE; TIAZOFURIN; UNCLASSIFIED DRUG;

ARTICLE; DEHYDROGENATION; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; NONHUMAN; POLYMERIZATION;

ANIMALS; ANTIVIRAL AGENTS; AZA COMPOUNDS; CARBOHYDRATES; CERCOPITHECUS AETHIOPS; CYSTEINE; DNA VIRUSES; FIBROBLASTS; HELA CELLS; HUMANS; MOLECULAR MIMICRY; PYRROLIDINES; RIBAVIRIN; RNA VIRUSES; VERO CELLS;

EID: 84856884895     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770.2011.643848     Document Type: Article

References (51)

1. (a) Pankiewicz, K.W.; Patterson, S.E.; Plack, P.L.; Jayram, H.N.; Risal, D.; Goldstein, B.M.; Stuyver, L.J.; Schinazi, R.F. Cofactor mimics as selective inhibitors of NAD-dependent inosine monophosphate dehydrogenase (IMPDH)-the major therapeutic target. Curr. Med. Chem. 2004, 11, 887-900. (Pubitemid 38428647)
2. (b) Hedstrom, L. IMP dehydrogenase: structure, mechanism, and inhibition. Chem. Rev. 2009, 109, 2903-2928.
3. (c) Grifantini, M. Tiazofurine ICN Pharmaceuticals. Curr. Opin. Invest. Drugs 2000, 1, 257-262.
4. (d) Vranić-Mandušć, V.; Subota, V.; Savovski, K.; Medić, L.; Dramićanin, T.; Jozanov-Stankov, O.; Popov-Ćelektetić, D.; Jokanović, M.; Dimtrijević, B. Erythrocytotoxicity of tiazofurin in vivo and in vitro detected by scanning probe microscopy. Toxicol. Lett. 2004, 146, 275-284. (Pubitemid 37542403)
5. (e) Franchetti, P.; Marchetti, S.; Cappellacci, L.; Yalowitz, J.A.; Jayaram, H.N.; Goldstein, B.M.; Grifantini, M. A new C-nucleoside analogue of tiazofurin: synthesis and biological evaluation of 2-beta-D- ribofuranosylimidazole-4-carboxamide (imidazofurin). Bioorg. Med. Chem. Lett. 2001, 11, 67-69. (Pubitemid 32006126)
6. (f) Popsavin, M.; Torović, L.; Svircev, M.; Kojić, V.; Bogdanović, G.; Popsavin, V. Synthesis and antiproliferative activity of two new tiazofurin analogues with 2′-amido functionalities. Bioorg. Med. Chem. Lett. 2006, 16, 2773-2776.
7. (a) Nair, V.; Shu, Q. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery. Antivir. Chem. Chemother. 2007, 18, 245-258. (Pubitemid 350220744)
8. (b) Huggins, J.W.; Robins, R.K.; Canonico, P.G. Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses. Antimicrob. Agents Chemother. 1984, 26, 476-480. (Pubitemid 14018080)
9. Kikuchi, Y.; Nishiyama, S.; Yamamura, S.; Kato, K.; Fujiwara, S.; Umezawa, K.; Terada, Y. Synthesis of C-oxetanosyl-thiazole and its carbocyclic analog nucleosides as potential chemotherapeutic agents. Bioorg. Med. Chem. Lett. 1996, 6, 1897-1900. (Pubitemid 26270468)
10. Cai, D.; Lin, K.; Song, M.; You, T. Ring-expanded C-Nucleoside analogues of tiazofurin. Synth. Commun. 2004, 34, 159-170. (Pubitemid 38249792)
11. Xiang, Y.; Teng, Q.; Chu, C.K. Novel C-nucleoside analogs of 1,3-dioxolane: synthesis of enantiomeric (2′R,4′S)- and (2′S,4′R)-2-[4-(hydroxymethyl)-1,3-dioxolan-2-yl]-1, 3-thiazol-4-carboxamide. Tetrahedron Lett. 1995, 36, 3781-3784.
12. (a) Chiacchio, U.; Rescifina, A.; Saita, M.G.; Iannazzo, D.; Romeo, G.; Mates, J.A.; Tejero, T.;Merino, P. Zinc(II) triflate-controlled 1,3-dipolar cycloadditions of C-(2-thiazolyl)nitrones: application to the synthesis of a novel isoxazolidinyl analogue of tiazofurin. J. Org. Chem. 2005, 70, 8991-9001; (Pubitemid 41532834)
13. (b) Merino, P.; Tejero, T.; Unzurrunzaga, F.J.; Franco, S.; Chiacchio, U.; Saita, M.G.; Iannazzo, D.; Piperno, A.; Romeo, G. An efficient approach to enantiomeric isoxazolidinyl analogs of tiazofurin based on nitrone cycloadditions. Tetrahedron: Asymm. 2005, 16, 3865-3876. (Pubitemid 41750978)
14. Haraguchi, K.; Matsui, H.; Takami, S.; Tanaka, H. Additive Pummerer reaction of 3,5-O-(di-tertbutyl) silylene-4-thiofuranoid glycal: a high-yield and β-selective entry to 4′-thioribonucleosides. J. Org. Chem. 2009, 74, 2616-2619.
15. Kini, G.D.; Hennen,W.J.; Robins, R.K. Synthesis of 2-(4-amino-4-deoxy- beta-D-ribofuranosyl)thiazole-4-carboxamide, a carbon-linked nucleoside with a free pyrrolidine sugar. J. Org. Chem. 1986, 51, 4436-4439.
16. (a) Mironiuk-Puchalska, E.; Kołaczkowska, E.; Sas, W. Synthesis of ((±)-branched-chain azaisonucleosides via Michael addition of 5-niro-2,2-pentamethylene-1,3-dioxane tomethyl 2-bromoacrylate. Tetrahedron Lett. 2002, 43, 8351-8354. (Pubitemid 35223371)
17. (b) Koszytkowska-Stawínska, M.; Mironiuk-Puchalska, E.; Sas, W. Synthesis of 1-pyrrolidine 1-oxides analogous to pseudouridine. Tetrahedron Lett. 2011, 52, 1866-1870.
18. (a) Yokoyama, M.; Momotake, A. Synthesis and biological activity of azanucleosides. Synthesis 1999, 9, 1541-1554. (Pubitemid 29415931)
19. (b) Deng, L.; Scharer, O.D.; Verdine, G.L. Unusually strong binding of a designed transition-state analog to a base-excision DNA repair protein. J. Am. Chem. Soc. 1997, 119, 7865-7866. (Pubitemid 27376403)
20. (c) Lewandowicz, A.; Shi,W.; Evans, G.B.; Tyler, P.C.; Furneaux, R.H.; Basso, L.A.; Santos, D.S.; Almo, S.C.; Schramm, V.L. Over-the-barrier transition state analogues and crystal structure with Mycobacterium tuberculosis purine nucleoside phosphorylase. Biochemistry 2003, 42, 6057-6066. (Pubitemid 36605108)
21. (d) Murkin, A.S.; Tyler, P.C.; Schramm, V.L. Transition state interactions revealed in purine nucleoside phosphorylase by binding isotope effects. J. Am. Chem. Soc. 2008, 130, 2166-2167. (Pubitemid 351287987)
22. (e) Schramm, V.L.; Tyler, P.C. Imino-sugar-based nucleosides. Curr. Top. Med. Chem. 2003, 3, 525-540.
23. (a) De Clercq, E. New approaches toward anti-HIV chemotherapy. J. Med. Chem. 2005, 48, 1297-1313. (Pubitemid 40364540)
24. (b)De Clercq, E. Antiviral drugs in current clinical use. J. Clin. Virol. 2004, 30, 115-133. (Pubitemid 38582018)
25. (c)De Clercq, E. Antiviral drugs: current state of the art. J. Clin. Virol. 2001, 22, 73-89. (Pubitemid 32551952)
26. (d) De Clercq, E. Antivirals: current state of the art. Future Virol. 2008, 3, 393-405.
27. (a) Hrdlicka, P.J.; Andersen, N.K.; Jepsen, J.S., Hansen, F.G.; Haselmann, K.F.; Nielsen, C.; Wengel, J. Synthesis and biological evaluation of branched and conformationally restricted analogs of the anticancer compounds 3′-C-ethynyluridine (EUrd) and 3′-C-ethynylcytidine (ECyd). Bioorg. Med. Chem. 2005, 13, 2597-2621. (Pubitemid 40341663)
28. (b) Ichikawa, E.; Kato, K. Sugar-modified nucleosides in past 10 years, a review. Curr. Med. Chem. 2001, 8, 385-423. (Pubitemid 32409787)
29. (c) Chun, M.W.; Shin, D.H.; Moon, H.R.; Lee, J.; Park, H.; Jeong, L.S. Syntheses and antiviral activities of 1,3-dioxolanyl-, 1,3-oxathiolanyl- and 1,3-dithiolanylnucleosides with 2-hydroxymethyl substituents. Bioorg. Med. Chem. Lett. 1997, 7, 1475-1480. (Pubitemid 27235202)
30. (a) Stanchev, M.; Tabakova, S.; Videnov, G.; Golovinsky, E.; Jung, G. Synthesis and antimicrobial activity in vitro of new amino acids and peptides containing thiazole and oxazole moieties. Arch. Pharm. Pharm. Med. Chem. 1999, 332, 297-304. (Pubitemid 29446514)
31. (b) Oh, C.H.; Cho, H.-W.; Baek, D.; Cho, J.-H. Synthesis and antibacterial activity of 1-beta-methyl-2-(5-substituted thiazolo pyrrolidin-3-ylthio)carbapenem derivatives. Eur. J. Med. Chem. 2002, 37, 743-754. (Pubitemid 35279242)
32. (c) Navarre, J.M.; Guianviarc'h, D.; Farese-Di Giorgio, A.; Condom, R.; Benhida, R. A short and highly stereoselective synthesis of α-(2- aminothiazolyl)-C-nucleosides. Tetrahedron Lett. 2003, 44, 2199-2202. (Pubitemid 36197785)
33. (d) Hennen, W.J.; Hinshaw, B.C.; Riley, T.A.; Wood, S.G.; Robins, R.K. Synthesis of 4-substituted 5-amino-2-((-D-ribofuranosyl)thiazoles and 4-substituted 5-amino-2-((-D-ribofuranosyl)selenazoles and their respective conversion into 2-((-Dribofuranosyl) thiazolo[5,4-d]pyrimidines and 2-((-D-ribofuranosyl)selenazolo[5,4-d]pyrimidines. A new synthesis of tiazofurin and selenofurin. J. Org. Chem. 1985, 50, 1741-1746. (Pubitemid 15097114)
34. (e) Srivastava, P.C.; Revankar, G.R.; Robins, R.K. Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-(-D-ribofuranosylthiazole-4-carboxamide. J. Med. Chem. 1984, 27, 266-269. (Pubitemid 14160609)
35. (a) Muri, E.M.F.; Mishra, H.; Stein, S.M.; Williamson, J.S. Molecular modeling, synthesis and biological evaluation of heterocyclic hydroxamic acids designed as Helicobacter pylori urease inhibitors. Lett. Drug Des. Discov. 2004, 1, 30-34.
36. (b) Anandan, S.K.; Ward, J.S.; Brokx, R.D.; Denny, T.; Bray, M.R.; Palet, D.V.; Xiao, X.Y. Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors. Bioorg. Med. Chem. Lett. 2007, 17, 5995-5999. (Pubitemid 47449745)
37. (c) Charrier, C.; Roche, J.; Gesson, J.P.; Bertrand, P. Antiproliferative activities of a library of hybrids between indanones and HDAC inhibitor SAHA and MS-275 analogues. Med. Chem. Lett. 2007, 17, 6142-6146. (Pubitemid 47552840)
38. (a) Mahalingam, V.; Chitrapriya, N.; Zeller, M.; Natarajan, K. Ru(II)-DMSO complex containing aromatic and heterocyclic acid hydrazides: structure, electrochemistry and biological activity. Polyhedron 2009, 28, 1532-1540.
39. (b) Zahid, M.; Yasin, K.A.; Akhtar, T.; Rama, N.H.; Hameed, S.; Al.-Masoudi, N.A.; Loddo, R.; La Colla, P. Synthesis and in vitro antiproliferative activity of new adamantylthiazolyl-1,3,4-oxadiazoles. ARKIVOC 2009, 85-93.
40. (c) Mohareb, R.M.; Fleita, D.H.; Sakka, O.K. Novel synthesis of hydrazide-hydrazone derivatives and their utilization in the synthesis of coumarin, pyridine, thiazole and thiophene derivatives with antitumor activity. Molecules 2011, 16, 16-27.
41. Koszytkowska-Stawínska, M.; Sas, W.; Sowínska, A. The synthesis of novel 5,5-bis(hydroxymethyl)-1-pyrrolidine[2,2-bis(hydroxymethyl)- 3,4-dihydro-2H-pyrrole] 1-oxide derivatives. J. Chem. Res.(S) 1996, 162-163. (Pubitemid 126458451)
42. (a) Arakawa, Y.; Yoshifuji, S. Synthesis of (3S, 4S)-3, 4-dihydroxyprolines from L-tartaric acid. Chem. Pharm. Bull. 1991, 39, 2219-2224.
43. (b) Han, B.; Wang, Z.; Jaun, B.; Krishnamurtthy, R.; Eschenmoser, A. C-Nucleosidations with 2,6-diamino-5,8-diaza-7,9-dicarba-purine. Org. Lett. 2003, 5, 2071-2074. (Pubitemid 37140929)
44. De Souza, M.V.N. Synthesis and biological activity of natural thiazoles: an important class of heterocyclic compounds. J. Sulfur Chem. 2005, 4-5, 429-449.
45. (a) Ramasamy, K.S.; Lau, J.Y.N. A new synthesis methodology for tiazofurin. Nucleos. Nucleot. Nucl. 2001, 22, 1329-1331.
46. (b) Brown, R.S.; Dowden, J.; Moreau, C.; Potter, B.V.L. A concise route to tiazofurin. Tetrahedron Lett. 2002, 43, 6561-6562. (Pubitemid 35266582)
47. (c) Liang, C.W.; Kim, M.J.; Jeong, L.S.; Chun, M.W. Synthesis of 2-(3′-azido- and 3′-amino-3′-deoxy-beta-dribofuranosyl) thiazole-4-carboxamide. Nucleos. Nucleot. Nucl. 2003, 22, 2039-2048.
48. Muri, E.M.F.; Mishra, H.; Avery, M.A.; Williamson, A.J.S. Design and synthesis of heterocyclic hydroxamic acid derivatives as inhibitors ofHelicobacter pylori urease. Synth. Commun. 2003, 33, 1977-1995. (Pubitemid 36791474)
49. Newkome, G.R.; Gross, J.; Patri, A.K. Synthesis of unsymmetrical 5,5′-disubstituted 2,2′-bipyridines. J. Org. Chem. 1997, 62, 3013-3014.
50. (a) Vanderlinden, E.; Gökta, F.; Cesur, Z.; Froeyen, M.; Reed, M.L.; Russell, C.J.; Cesur, N.; Naesens, L. Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin. J. Virol. 2010, 84, 4277-4288.
51. (b) Naesens, L.; Vanderlinden, E.; Roth, E.; Jeko, J.; Andrei, G.; Snoeck, R.; Pannecouque, C.; Illyes, E.; Batta, G.; Herczegh, P.; Sztaricskai, F. Anti-influenza virus activity and structure-activity relationship of aglycoristocetin derivatives with cyclobutenedione carrying hydrophobic chains. Antiviral Res. 2009, 82, 89-94.